(Q35395985)

English

HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

medullary carcinoma

1 reference

based on heuristic

inferred from title

author name string

Feinmesser M

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sulkes A

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Morgenstern S

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sulkes J

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Stern S

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Okon E

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

286-291

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

The class II molecules of the human and murine major histocompatibility complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: Evidence using monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

The immunopathology of sequential tumor biopsies in patients treated with interleukin-2. Correlation of response with T-cell infiltration and HLA-DR expression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

HLA-DR antigens on differentiating human mammary gland epithelium and breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Experimental strategies for modification of histocompatibility antigens in tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Histocompatibility antigens on murine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Expression of HLA-A, -B, -C, -DR, -DP, -DQ, and of HLA-D-associated invariant chain (Ii) in non-neoplastic mammary epithelium, fibroadenoma, adenoma, and carcinoma of the breast.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Patterns of Human Tumor-Infiltrating Lymphocytes in 120 Human Cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Effect of epidermal growth factor in HLA class I and class II transcription and protein expression in human breast adenocarcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Immunoperoxidase techniques: practical and theoretical aspects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

12 July 2018

Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

26 September 2018

Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

26 September 2018

Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1731169

26 September 2018

Presence of HLA-D/DR antigens on the membrane of breast tumour cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of HLA-D sub-region products on human colorectal carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA class II sublocus expression in benign and malignant breast epithelium

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical correlates of response to recombinant interleukin-2-based immunotherapy in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of HLA-D/Ii antigen expression in breast carcinoma with local lymphohistiocytic infiltration reveals considerable dysregulation in a subset of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity of beta 2-microglobulin in human breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medullary carcinoma of the breast. Overdiagnosis of a prognostically favorable neoplasm

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-2-microglobulin expression in relation to amplification of oncogenes and prognosis in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can the HLA phenotype be used as a prognostic factor in breast carcinomas?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of T-cell infiltrates, expression of beta 2-microglobulin and HLA-DR antigens in breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/10823125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JCP.53.4.286

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35395985&oldid=1628744533"